Phosphoinositide-specific phospholipase C?1 inhibition induces autophagy in human colon cancer and hepatocellular carcinoma cells.
Ontology highlight
ABSTRACT: Phosphoinositide-specific phospholipase C (PLC) ?1 has been reported to be involved in cancer cell proliferation and metastasis. However, whether PLC?1 modulates autophagy and the underlying mechanism remains unclear. Here, we investigated the relationship between PLC?1 and autophagy in the human colon cancer cell line HCT116 and hepatocellular carcinoma cell line HepG2. The results indicated that PLC?1 inhibition via lentivirus-mediated transduction with shRNA/PLC?1 or transient transfection with pRK5-PLC?1 (Y783A) vector increased LC3B-II levels and the number of autophagic vacuoles and decreased p62 levels. Addition of an autophagy inhibitor led to LC3B and p62 accumulation. Furthermore, AMPK activation promoted the autophagy induced by PLC?1 inhibition by blocking the FAK/PLC?1 axis. In addition, PLC?1 inhibition either blocked the mTOR/ULK1 axis or enhanced dissociation of the Beclin1-IP3R-Bcl-2 complex to induce autophagy. Taken together, our findings revealed that PLC?1 inhibition induced autophagy and the FAK/PLC?1 axis is a potential downstream effector of the AMPK activation-dependent autophagy signalling cascade. Both blockade of the mTOR/ULK1 axis and dissociation of the Beclin1-IP3R-Bcl-2 complex contributed to the induction of autophagy by PLC?1 inhibition. Consequently, these findings provide novel insight into autophagy regulation by PLC?1 in colon cancer and hepatocellular carcinoma cells.
SUBMITTER: Dai L
PROVIDER: S-EPMC5654964 | biostudies-literature | 2017 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA